CLDT Stock Analysis: Chatham Lodging Trust REIT | NYSE
REIT - Hotel & Motel | NYSE, USA | Market Cap: 688m USD | 12M Return: 130.7% | US16208T1025 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.07M
Qual. Beats: 0
Rev. Trend: -66.2%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Chatham Lodging Trust (NYSE: CLDT) is a self-advised, publicly traded real estate investment trust (REIT) that invests primarily in upscale, extended-stay hotels and premium-branded, select-service hotels. The company owns 39 hotels with 5,610 rooms/suites across 18 states and the District of Columbia. Founded on October 26, 2009, and incorporated in Maryland, the trust trades as a small-cap stock with a market capitalization of approximately $670 million and has been listed since its April 2010 IPO.
As a REIT operating in the Hotel & Resort sub-industry, CLDT benefits from pass-through taxation structure but is required to distribute the majority of its taxable income to shareholders. Hotel REITs tend to be more cyclical than other REIT categories, with performance closely tied to broader economic conditions, corporate travel demand, and leisure tourism trends. The trusts focus on select-service and extended-stay properties typically involves lower operating costs and more stable occupancy patterns compared to full-service or luxury hotel segments, as extended-stay guests often stay for multiple weeks.
- Extended-stay hotel RevPAR growth lifts revenue
- Rising interest rates pressure REIT dividend yields and borrowing costs
- Select-service portfolio acquisitions expand room count
| Net Income: 12.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -2.20 > 1.0 |
| NWC/Revenue: -7.93% < 20% (prev -44.07%; Δ 36.15% < -1%) |
| CFO/TA 0.06 > 3% & CFO 76.8m > Net Income 12.1m |
| Net Debt (442.4m) to EBITDA (96.2m): 4.60 < 3 |
| Current Ratio: 0.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (50.0m) vs 12m ago 0.88% < -2% |
| Gross Margin: 28.45% > 18% (prev 34.79%; Δ -6.34% > 0.5%) |
| Asset Turnover: 24.83% > 50% (prev 26.06%; Δ -1.23% > 0%) |
| Interest Coverage Ratio: 1.54 > 6 (EBIT TTM 36.6m / Interest Expense TTM 23.8m) |
| A: -0.02 (Total Current Assets 14.3m - Total Current Liabilities 38.2m) / Total Assets 1.23b |
| B: -0.25 (Retained Earnings -308.9m / Total Assets 1.23b) |
| C: 0.03 (EBIT TTM 36.6m / Avg Total Assets 1.21b) |
| D: 1.53 (Book Value of Equity 721.7m / Total Liabilities 472.3m) |
| Altman-Z'' = 0.86 = B |
| DSRI: 0.66 (Receivables 2.97m/4.68m, Revenue 301.5m/311.2m) |
| GMI: 1.22 (GM 34.79% / 28.45%) |
| AQI: 354.7 (AQ_t 0.97 / AQ_t-1 0.00) |
| SGI: 0.97 (Revenue 301.5m / 311.2m) |
| TATA: -0.05 (NI 12.1m - CFO 76.8m) / TA 1.23b) |
| Beneish M = 206.6 (Cap -4..+1) = D |
As of October 22, 2026, the stock is trading at USD 14.33 with a total of 937,734 shares traded. Over the past week, the price has changed by +3.62%, over one month by +9.87%, over three months by +7.34% and over the past year by +130.73%.
Current recommended Stop Loss: 13.30 (which is 7.2% or 2.6 ATR below the current price).
Chatham Lodging Trust REIT has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CLDT.
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.3 | 0% |
P/E Trailing = 175.625
P/E Forward = 238.0952
P/S = 2.2957
P/B = 0.844
P/EG = 2.2824
Revenue TTM = 301.5m USD
EBIT TTM = 36.6m USD
EBITDA TTM = 96.2m USD
Long Term Debt = 414.3m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 453.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 19.7m
Net Debt = 442.4m USD (calculated: Debt 453.8m - CCE 11.3m)
Enterprise Value = 1.13b USD (688.0m + Debt 453.8m - CCE 11.3m)
Interest Coverage Ratio = 1.54 (Ebit TTM 36.6m / Interest Expense TTM 23.8m)
EV/FCF = 17.87x (Enterprise Value 1.13b / FCF TTM 63.3m)
FCF Yield = 5.60% (FCF TTM 63.3m / Enterprise Value 1.13b)
FCF Margin = 20.98% (FCF TTM 63.3m / Revenue TTM 301.5m)
Net Margin = 4.00% (Net Income TTM 12.1m / Revenue TTM 301.5m)
Gross Margin = 28.45% ((Revenue TTM 301.5m - Cost of Revenue TTM 215.7m) / Revenue TTM)
Gross Margin QoQ = 40.69% (prev -1.63%)
Tobins Q-Ratio = 0.92 (Enterprise Value 1.13b / Total Assets 1.23b)
Interest Expense / Debt = 5.24% (Interest Expense 23.8m / Debt 453.8m)
Taxrate = 1.01% (124k / 12.3m)
NOPAT = 36.2m (EBIT 36.6m * (1 - 1.01%))
Current Ratio = 0.37 (Total Current Assets 14.3m / Total Current Liabilities 38.2m)
Debt / Equity = 0.63 (Debt 453.8m / totalStockholderEquity, last quarter 721.7m)
Debt / EBITDA = 4.60 (Net Debt 442.4m / EBITDA 96.2m)
Debt / FCF = 6.99 (Net Debt 442.4m / FCF TTM 63.3m)
Total Stockholder Equity = 733.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.99% (Net Income 12.1m / Total Assets 1.23b)
RoE = 1.64% (Net Income TTM 12.1m / Total Stockholder Equity 733.7m)
RoCE = 3.18% (EBIT 36.6m / Capital Employed (Equity 733.7m + L.T.Debt 414.3m))
RoIC = 3.06% (NOPAT 36.2m / Invested Capital 1.18b)
WACC = 6.29% (E(688.0m)/V(1.14b) * Re(7.02%) + D(453.8m)/V(1.14b) * Rd(5.24%) * (1-Tc(0.01)))
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 1.38 | Cagr: 1.00%
[DCF] Terminal Value 73.10% ; FCFF base≈72.9m ; Y1≈64.0m ; Y5≈51.7m
[DCF] Fair Price = 8.31 (EV 829.5m - Net Debt 442.4m = Equity 387.0m / Shares 46.6m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.57 | # QB: 0
Revenue Correlation: -66.18 | Revenue CAGR: -1.93% | SUE: 1.05 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.05 | Chg30d=+0.00% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=-0.07 | Chg30d=+12.50% | Revisions=+0% | GrowthEPS=-150.0% | GrowthRev=+7.5%
EPS next Year (2027-12-31): EPS=-0.10 | Chg30d=+9.09% | Revisions=+0% | GrowthEPS=-42.9% | GrowthRev=+3.6%